vs
アレジオン（ALLE）とMirion Technologies, Inc.（MIR）の財務データ比較。上の社名をクリックして会社を切り替えられます
アレジオンの直近四半期売上が大きい（$1.0B vs $277.4M、Mirion Technologies, Inc.の約3.7倍）。アレジオンの純利益率が高く（14.3% vs 6.2%、差は8.0%）。アレジオンの前年同期比売上増加率が高い（9.3% vs 9.1%）。アレジオンの直近四半期フリーキャッシュフローが多い（$200.5M vs $63.2M）。過去8四半期でMirion Technologies, Inc.の売上複合成長率が高い（20.0% vs 7.5%）
アレジオン（Allegion plc）は世界中で機械式・電子式セキュリティ製品およびソリューションを製造販売している。取扱製品はドアクローザー、出入り口制御装置、錠前、電子入退室管理システム、勤怠管理システム、ドアシステムや各種付属部品など多岐にわたり、商業施設、公共施設、住宅などの顧客に提供している
ミリオンテクノロジーズ社は放射線検出、モニタリング、安全ソリューションのグローバルプロバイダーです。主力製品は個人線量測定システム、放射線画像装置、放射線リスク管理ソフトウェアで、原子力発電、医療、防衛、産業分野を中心に世界各国の顧客にサービスを提供しています。
ALLE vs MIR — 直接比較
損益計算書 — Q4 2025 vs Q4 2025
| 指標 | | |
|---|---|---|
| 売上 | $1.0B | $277.4M |
| 純利益 | $147.5M | $17.3M |
| 粗利率 | 44.5% | 48.8% |
| 営業利益率 | 20.3% | 9.2% |
| 純利益率 | 14.3% | 6.2% |
| 売上前年比 | 9.3% | 9.1% |
| 純利益前年比 | 2.4% | 15.3% |
| EPS（希薄化後） | $1.70 | $0.07 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.0B | $277.4M | ||
| Q3 25 | $1.1B | $223.1M | ||
| Q2 25 | $1.0B | $222.9M | ||
| Q1 25 | $941.9M | $202.0M | ||
| Q4 24 | $945.6M | $254.3M | ||
| Q3 24 | $967.1M | $206.8M | ||
| Q2 24 | $965.6M | $207.1M | ||
| Q1 24 | $893.9M | $192.6M |
| Q4 25 | $147.5M | $17.3M | ||
| Q3 25 | $188.4M | $2.9M | ||
| Q2 25 | $159.7M | $8.3M | ||
| Q1 25 | $148.2M | $300.0K | ||
| Q4 24 | $144.1M | $15.0M | ||
| Q3 24 | $174.2M | $-13.6M | ||
| Q2 24 | $155.4M | $-11.7M | ||
| Q1 24 | $123.8M | $-25.8M |
| Q4 25 | 44.5% | 48.8% | ||
| Q3 25 | 45.8% | 46.8% | ||
| Q2 25 | 45.6% | 46.0% | ||
| Q1 25 | 44.9% | 47.6% | ||
| Q4 24 | 44.1% | 48.1% | ||
| Q3 24 | 44.7% | 44.9% | ||
| Q2 24 | 44.4% | 47.0% | ||
| Q1 24 | 43.8% | 45.2% |
| Q4 25 | 20.3% | 9.2% | ||
| Q3 25 | 21.8% | 3.3% | ||
| Q2 25 | 21.5% | 4.4% | ||
| Q1 25 | 20.9% | 4.3% | ||
| Q4 24 | 19.5% | 11.4% | ||
| Q3 24 | 22.2% | -0.8% | ||
| Q2 24 | 21.6% | 1.1% | ||
| Q1 24 | 19.3% | -2.5% |
| Q4 25 | 14.3% | 6.2% | ||
| Q3 25 | 17.6% | 1.3% | ||
| Q2 25 | 15.6% | 3.7% | ||
| Q1 25 | 15.7% | 0.1% | ||
| Q4 24 | 15.2% | 5.9% | ||
| Q3 24 | 18.0% | -6.6% | ||
| Q2 24 | 16.1% | -5.6% | ||
| Q1 24 | 13.8% | -13.4% |
| Q4 25 | $1.70 | $0.07 | ||
| Q3 25 | $2.18 | $0.01 | ||
| Q2 25 | $1.85 | $0.03 | ||
| Q1 25 | $1.71 | $0.00 | ||
| Q4 24 | $1.65 | $0.08 | ||
| Q3 24 | $1.99 | $-0.07 | ||
| Q2 24 | $1.77 | $-0.06 | ||
| Q1 24 | $1.41 | $-0.13 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $356.2M | $412.3M |
| 総負債低いほど良い | $2.0B | — |
| 株主資本純資産 | $2.1B | $1.9B |
| 総資産 | $5.2B | $3.6B |
| 負債/資本比率低いほどレバレッジが低い | 0.96× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $356.2M | $412.3M | ||
| Q3 25 | $302.7M | $933.2M | ||
| Q2 25 | $656.8M | $262.6M | ||
| Q1 25 | $494.5M | $185.8M | ||
| Q4 24 | $503.8M | $175.2M | ||
| Q3 24 | $878.9M | $133.3M | ||
| Q2 24 | $747.5M | $122.2M | ||
| Q1 24 | $391.8M | $120.2M |
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.1B | $444.8M | ||
| Q2 25 | $2.1B | $444.9M | ||
| Q1 25 | $2.0B | $686.6M | ||
| Q4 24 | $2.0B | $686.4M | ||
| Q3 24 | $2.4B | $685.1M | ||
| Q2 24 | $2.4B | $684.1M | ||
| Q1 24 | $2.0B | $685.5M |
| Q4 25 | $2.1B | $1.9B | ||
| Q3 25 | $1.9B | $1.8B | ||
| Q2 25 | $1.8B | $1.5B | ||
| Q1 25 | $1.6B | $1.5B | ||
| Q4 24 | $1.5B | $1.5B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.4B | $1.5B | ||
| Q1 24 | $1.4B | $1.5B |
| Q4 25 | $5.2B | $3.6B | ||
| Q3 25 | $5.2B | $3.5B | ||
| Q2 25 | $4.9B | $2.7B | ||
| Q1 25 | $4.6B | $2.6B | ||
| Q4 24 | $4.5B | $2.6B | ||
| Q3 24 | $5.0B | $2.7B | ||
| Q2 24 | $4.8B | $2.6B | ||
| Q1 24 | $4.3B | $2.6B |
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.07× | 0.24× | ||
| Q2 25 | 1.16× | 0.30× | ||
| Q1 25 | 1.24× | 0.46× | ||
| Q4 24 | 1.33× | 0.46× | ||
| Q3 24 | 1.53× | 0.45× | ||
| Q2 24 | 1.69× | 0.45× | ||
| Q1 24 | 1.49× | 0.47× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $240.1M | $73.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $200.5M | $63.2M |
| FCFマージンFCF / 売上 | 19.4% | 22.8% |
| 設備投資強度設備投資 / 売上 | 3.8% | 3.5% |
| キャッシュ転換率営業CF / 純利益 | 1.63× | 4.22× |
| 直近12ヶ月FCF直近4四半期 | $685.7M | $106.9M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $240.1M | $73.0M | ||
| Q3 25 | $229.5M | $22.3M | ||
| Q2 25 | $209.7M | $12.4M | ||
| Q1 25 | $104.5M | $35.6M | ||
| Q4 24 | $219.0M | $60.8M | ||
| Q3 24 | $231.9M | $17.1M | ||
| Q2 24 | $173.0M | $15.2M | ||
| Q1 24 | $51.1M | $6.0M |
| Q4 25 | $200.5M | $63.2M | ||
| Q3 25 | $209.8M | $13.0M | ||
| Q2 25 | $192.0M | $3.6M | ||
| Q1 25 | $83.4M | $27.1M | ||
| Q4 24 | $194.9M | $49.1M | ||
| Q3 24 | $212.0M | $3.9M | ||
| Q2 24 | $152.1M | $4.1M | ||
| Q1 24 | $23.9M | $-6.8M |
| Q4 25 | 19.4% | 22.8% | ||
| Q3 25 | 19.6% | 5.8% | ||
| Q2 25 | 18.8% | 1.6% | ||
| Q1 25 | 8.9% | 13.4% | ||
| Q4 24 | 20.6% | 19.3% | ||
| Q3 24 | 21.9% | 1.9% | ||
| Q2 24 | 15.8% | 2.0% | ||
| Q1 24 | 2.7% | -3.5% |
| Q4 25 | 3.8% | 3.5% | ||
| Q3 25 | 1.8% | 4.2% | ||
| Q2 25 | 1.7% | 3.9% | ||
| Q1 25 | 2.2% | 4.2% | ||
| Q4 24 | 2.5% | 4.6% | ||
| Q3 24 | 2.1% | 6.4% | ||
| Q2 24 | 2.2% | 5.4% | ||
| Q1 24 | 3.0% | 6.6% |
| Q4 25 | 1.63× | 4.22× | ||
| Q3 25 | 1.22× | 7.69× | ||
| Q2 25 | 1.31× | 1.49× | ||
| Q1 25 | 0.71× | 118.67× | ||
| Q4 24 | 1.52× | 4.05× | ||
| Q3 24 | 1.33× | — | ||
| Q2 24 | 1.11× | — | ||
| Q1 24 | 0.41× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ALLE
| Products | $750.2M | 73% |
| Allegion International | $237.7M | 23% |
| Services | $45.2M | 4% |
MIR
| Transferred Over Time | $96.6M | 35% |
| Services | $65.0M | 23% |
| Cancer Care | $61.8M | 22% |
| Labs And Research | $34.0M | 12% |
| Other Care | $20.7M | 7% |
